T cell Tolerance to Enteric Commensal Bacteria
T 细胞对肠道共生细菌的耐受性
基本信息
- 批准号:10424555
- 负责人:
- 金额:$ 50.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-09 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AntigensAutoantigensBacteriaBacterial AntigensCD4 Positive T LymphocytesCD8B1 geneCellsCellular biologyClonal DeletionCollectionComplexDevelopmentDiscriminationDiseaseEconomic BurdenEnteralEnvironmentExcisionFOXP3 geneFutureGastrointestinal tract structureGoalsHealthHeterogeneityImmuneImmune ToleranceImmune responseImmune systemImmunodominant EpitopesInflammatoryInflammatory Bowel DiseasesInterleukin-10KnowledgeLongevityLymphocyteMediatingMemoryMusPathogenesisPathogenicityPathway interactionsPeptidesPeripheralPersonsPhenotypePopulationProcessPropertyReagentRegulatory PathwayRegulatory T-LymphocyteReporter GenesResolutionRoleShapesSocietiesSpecificitySystemT cell clonalityT-LymphocyteT-Lymphocyte SubsetsTechnologyTestingTherapeuticThymus GlandTransgenic Organismsantigen-specific T cellsbasecommensal bacteriacommensal microbescytotoxicenteric infectiongastrointestinal systemgut microbiotaintestinal epitheliumintraepithelialnovel strategiessingle-cell RNA sequencingsocialtranscriptomics
项目摘要
PROJECT SUMMARY
The gastrointestinal tract is colonized by an enormous collection of commensal bacteria living in
harmony with the host. This poses a challenge for the immune system which must promote tolerance to
beneficial bacteria species while still providing protection against pathogenic species. Indeed, a breakdown in
such discrimination is thought to be a major underlying cause of inflammatory bowel disease (IBD).
Unlike self-antigens, antigens derived from commensal microbiota are unlikely to be presented in the
thymus to impact central T cell tolerance. Rather, specific tolerance to these antigens must rely exclusively on
peripheral mechanisms acting within the immune environment of the gut. However, these mechanisms and
the quality of the tolerance they mediate are unclear. To better investigate these processes, our lab has
developed peptide:MHCII tetramer reagents that enable us to directly identify rare gut CD4+ T cells with
specificity to immunodominant epitopes from several different commensal bacteria species in mice. Our
preliminary studies support varied roles for deletion, Treg, and Tr1 cell development depending on the bacteria
species. To provide better resolution of commensal antigen-specific T cell phenotypes as well as the
heterogeneity of these phenotypes within the overall antigen-specific population, we are combining our use of
tetramers with single cell RNA-seq transcriptomics to comprehensively define phenotypic and clonal
heterogeneity within distinct commensal antigen-specific CD4+ T cell populations.
The overarching goal of this project is to understand the mechanisms by which T cells maintain immune
tolerance to specific commensal bacteria of the gastrointestinal tract so that they may ultimately be
manipulated for therapeutic benefit. We hypothesize that tolerance to commensal bacterial antigens is
maintained by multiple CD4+ T cell fates, each making unique but overlapping functional contributions that
collectively establish durable tolerance in the face of the dynamic gut environment. We will test this hypothesis
by 1) defining developmental fates for commensal bacterial antigen-specific CD4+ T cells that contribute to
immune tolerance, and 2) characterizing the function of commensal antigen-specific regulatory T cell subsets.
项目总结
胃肠道内寄生着大量共生细菌。
与主人和睦相处。这对免疫系统构成了挑战,免疫系统必须促进对
有益的细菌物种,同时仍提供对致病物种的保护。事实上,中国经济的崩溃
这种歧视被认为是炎症性肠病(IBD)的主要潜在原因。
与自身抗原不同,来自共生微生物区系的抗原不太可能出现在
胸腺影响中枢T细胞耐受性。相反,对这些抗原的特异性耐受性必须完全依赖于
作用于肠道免疫环境内的外周机制。然而,这些机制和
他们调停的容忍程度如何尚不清楚。为了更好地研究这些过程,我们的实验室已经
开发的多肽:MHCII四聚体试剂,使我们能够直接识别罕见的肠道CD4+T细胞
小鼠体内几种不同共生细菌的免疫优势表位的特异性。我们的
初步研究支持缺失、Treg和TR1细胞发育的不同角色取决于细菌
物种。为了更好地分辨共生抗原特异的T细胞表型以及
这些表型在整个抗原特异性人群中的异质性,我们正在结合我们的使用
用单细胞RNA-SEQ转录组的四聚体综合定义表型和克隆性
不同共生抗原特异性的CD4+T细胞群体中的异质性。
这个项目的首要目标是了解T细胞维持免疫的机制
对胃肠道特定共生菌的耐受性,以便它们最终可能
为了治疗的好处而操控。我们假设对共生细菌抗原的耐受性是
由多个CD4+T细胞命运维持,每个细胞都做出独特但重叠的功能贡献,
面对动态的肠道环境,集体建立持久的容忍度。我们将检验这一假设
通过1)确定共生细菌抗原特异性CD4+T细胞的发育命运,这些细胞有助于
免疫耐受,以及2)共生抗原特异性调节性T细胞亚群的功能特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James J Moon其他文献
BATF2 suppresses cancer initiation by promoting γδ T-cell-mediated immunity
BATF2 通过促进 γδ T 细胞介导的免疫来抑制癌症发生
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Wang Gong;Hulya Taner;Yuesong Wu;Wanqing Cheng;Kohei Okuyama;Zaiye Li;Shadmehr Demehri;Felipe Nor;Deepak Nagrath;Steven B Chinn;Christopher R Donnelly;James J Moon;Yuying Xie;Yu Leo Lei - 通讯作者:
Yu Leo Lei
James J Moon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James J Moon', 18)}}的其他基金
Biomaterials for modulating the gut microbiome for immune activation
用于调节肠道微生物组以激活免疫的生物材料
- 批准号:
10614059 - 财政年份:2022
- 资助金额:
$ 50.24万 - 项目类别:
T cell Tolerance to Enteric Commensal Bacteria
T 细胞对肠道共生细菌的耐受性
- 批准号:
10608196 - 财政年份:2021
- 资助金额:
$ 50.24万 - 项目类别:
T cell Tolerance to Enteric Commensal Bacteria
T 细胞对肠道共生细菌的耐受性
- 批准号:
10299254 - 财政年份:2021
- 资助金额:
$ 50.24万 - 项目类别:
Elicitation of mucosal immune responses against HIV
引发针对 HIV 的粘膜免疫反应
- 批准号:
9292510 - 财政年份:2016
- 资助金额:
$ 50.24万 - 项目类别:
Elicitation of mucosal immune responses against HIV
引发针对 HIV 的粘膜免疫反应
- 批准号:
9752434 - 财政年份:2016
- 资助金额:
$ 50.24万 - 项目类别:
Elicitation of mucosal immune responses against HIV
引发针对 HIV 的粘膜免疫反应
- 批准号:
9539522 - 财政年份:2016
- 资助金额:
$ 50.24万 - 项目类别:
Elicitation of mucosal immune responses against HIV
引发针对 HIV 的粘膜免疫反应
- 批准号:
9271737 - 财政年份:2016
- 资助金额:
$ 50.24万 - 项目类别:
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme
调整生物材料-免疫细胞相互作用治疗多形性胶质母细胞瘤
- 批准号:
9348653 - 财政年份:2016
- 资助金额:
$ 50.24万 - 项目类别:
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme
调整生物材料-免疫细胞相互作用治疗多形性胶质母细胞瘤
- 批准号:
9512575 - 财政年份:2016
- 资助金额:
$ 50.24万 - 项目类别:
相似海外基金
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
- 批准号:
10764143 - 财政年份:2023
- 资助金额:
$ 50.24万 - 项目类别:
Study of identification for autoantigens in a mouse model of pituitary dysfunction induced by CTLA-4 or PD-1 blockade
CTLA-4或PD-1阻断诱导的垂体功能障碍小鼠模型中自身抗原的鉴定研究
- 批准号:
22K08648 - 财政年份:2022
- 资助金额:
$ 50.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
- 批准号:
10545634 - 财政年份:2022
- 资助金额:
$ 50.24万 - 项目类别:
identification of autoantigens of autoimmune pancreatitis
自身免疫性胰腺炎自身抗原的鉴定
- 批准号:
21H02901 - 财政年份:2021
- 资助金额:
$ 50.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Genetic Basis of Variable Expression of Glycan Xeno-Autoantigens by Cattle
牛聚糖异种自身抗原变异表达的遗传基础
- 批准号:
DP200103734 - 财政年份:2020
- 资助金额:
$ 50.24万 - 项目类别:
Discovery Projects
The study to identify novel pathogenesis and autoantigens in patients with membranous nephropathy
确定膜性肾病患者新发病机制和自身抗原的研究
- 批准号:
19K08694 - 财政年份:2019
- 资助金额:
$ 50.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
- 批准号:
10356015 - 财政年份:2019
- 资助金额:
$ 50.24万 - 项目类别:
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
- 批准号:
10560561 - 财政年份:2019
- 资助金额:
$ 50.24万 - 项目类别:
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
- 批准号:
10093988 - 财政年份:2019
- 资助金额:
$ 50.24万 - 项目类别:
Identification of autoantigens presented by specific HLA class I alleles in aplastic anemia
再生障碍性贫血中特定 HLA I 类等位基因呈现的自身抗原的鉴定
- 批准号:
19H03686 - 财政年份:2019
- 资助金额:
$ 50.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




